Informations sur le produit
- 3-Hydroxy-6-methyl-2-phenylazopyridine
- 3-Pyridinol, 6-methyl-2-(2-phenyldiazenyl)-
- 3-Pyridinol, 6-methyl-2-(phenylazo)-
- 3-Pyridinol, 6-methyl-2-[(E)-2-phenyldiazenyl]-
- 6-Methyl-2-(2-phenyldiazenyl)-3-pyridinol
- Sib 1757
SIB 1757 is a potent, selective and orally active cannabinoid receptor 2 (CB2) agonist that was developed as a neuroprotective agent. It has been shown to be effective in the treatment of various nervous system diseases, including Parkinson's disease and Huntington's disease. SIB 1757 has been shown to have a potent antagonistic effect on glutamate receptors. This drug has also been shown to protect against the neurotoxicity associated with exposure to cytosolic calcium overload or glutamate receptor activation by blocking the release of calcium from intracellular stores. Furthermore, SIB 1757 has been shown to act as a dopamine D2 receptor antagonist and suppress striatal dopamine levels.
Propriétés chimiques
Question d’ordre technique sur : 3D-GBA99301 SIB 1757
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
